Comments
Glenmark has received establishment inspection report (EIR) from the US health regulator on closure of inspection of its Ankleshwar plant in Gujarat.
“Glenmark would like to state that its Ankleshwar plant received the EIR (establishment inspection report) yesterday. The EIR is issued by the FDA only if it finds the facility to be deemed acceptable,” Glenmark said in a BSE filing today.
The USFDA releases a copy of the EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency determines the inspection to be closed.
Glenmark was clarifying to the stock exchanges over a news report which claimed that its Ankleshwar plant received observations from the USFDA during its inspection in December 2016.
The stock was trading at Rs 905, up 1.58 per cent from its previous close on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.